CRISPR-Cas System Is an Effective Tool for Identifying Drug Combinations That Provide Synergistic Therapeutic Potential in Cancers

Despite numerous efforts, the therapeutic advancement for neuroblastoma and other cancer treatments is still ongoing due to multiple challenges, such as the increasing prevalence of cancers and therapy resistance development in tumors. To overcome such obstacles, drug combinations are one of the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yuna, Lee, Hyeong-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670858/
https://www.ncbi.nlm.nih.gov/pubmed/37998328
http://dx.doi.org/10.3390/cells12222593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670858/
https://www.ncbi.nlm.nih.gov/pubmed/37998328
http://dx.doi.org/10.3390/cells12222593

Ejemplares similares